
Elizabeth Buchbinder, MD
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
My primary focus is clinical trials looking at novel agents for the treatment of melanoma in advanced and early stage disease. I am also performing translational work to investigate pathways which could be targeted by novel agents.

Elizabeth Buchbinder, MD
Dana-Farber Cancer Institute